heavenclimb1
About
Long-acting two bronchodilator therapy (indacaterol/glycopyrronium) compared to nebulized short-acting dual bronchodilator (salbutamol/ipratropium) throughout long-term obstructive pulmonary disease: The double-blind, randomized, placebo-controlled tryout.